Kailera Therapeutics is trading at $11.73, up 5.46%, with no clear company-specific announcement identified to explain its September 29 pre-market rise. - Its latest identified company news was a September 16 announcement of investor conference participation, including a September 30 event; this does not establish a catalyst. - Major indices were little changed, offering no clear explanation for the gain. Pre-market volume and trading activity were not verified.